Solid-Nanoemulsion Preconcentrate for Oral Delivery of Paclitaxel: Formulation Design, Biodistribution, and γ Scintigraphy Imaging
Figure 10
Pharmacoscintigraphic evaluation of radiolabeled PAC formulation after 2 h: (a) i.v. administration of labeled Intaxel and (b) oral administration of labeled solid-nanoemulsion preconcentrate.
